Literature DB >> 18376856

Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery.

Ernesto R Soto1, Gary R Ostroff.   

Abstract

Nonviral gene delivery technologies have been developed using layer-by-layer self-assembly of nanomaterials held together by electrostatic interactions in order to provide nanoparticulate materials that protect and deliver DNA to cells. Here we report a new DNA delivery technology based on the in situ layer-by-layer synthesis of DNA nanoparticles caged within hollow yeast cell wall particles (YCWP). YCWP provide protection and facilitate oral and systemic receptor-targeted delivery of DNA payloads to phagocytic cells. The nanoparticles inside YCWP consist of a core of tRNA/polyethylenimine (PEI) followed by a DNA layer that is finally coated with a protective outer layer of PEI. Using fluorescein and rhodamine labeling of tRNA, PEI, and DNA, the layer-by-layer formation of the nanoparticles was visualized by fluorescent microscopy and quantitated by fluorescence spectroscopy and flow cytometry. Optimal conditions (tRNA:YCWP, PEI:YCWP ratios and DNA load levels) to synthesize YCWP encapsulated nanoparticles were determined from these results. The high in vitro transfection efficiency of this encapsulated DNA delivery technology was demonstrated by the transfection of NIH3T3-D1 cells with YCWP-tRNA/PEI/gWizGFP/PEI formulations containing low amounts of the plasmid gWizGFP per particle to maximally express green fluorescent protein (GFP).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376856     DOI: 10.1021/bc700329p

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  39 in total

1.  Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Sarika Agarwal; Sanjay Ram; Peter A Rice; Charles A Specht; Stuart M Levitz
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

Review 2.  Recent advances in oral vaccine development: yeast-derived β-glucan particles.

Authors:  Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

Review 3.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

4.  Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Authors:  George S Deepe; William R Buesing; Gary R Ostroff; Ambily Abraham; Charles A Specht; Haibin Huang; Stuart M Levitz
Journal:  Vaccine       Date:  2018-05-02       Impact factor: 3.641

5.  Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  MBio       Date:  2010-07-20       Impact factor: 7.867

6.  Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

Authors:  Myriam Aouadi; Gregory J Tesz; Sarah M Nicoloro; Mengxi Wang; My Chouinard; Ernesto Soto; Gary R Ostroff; Michael P Czech
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

7.  MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent.

Authors:  Sara Figueiredo; Juan Carlos Cutrin; Silvia Rizzitelli; Elisa De Luca; João Nuno Moreira; Carlos F G C Geraldes; Silvio Aime; Enzo Terreno
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

8.  Characterization and optimization of the glucan particle-based vaccine platform.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

Review 9.  Yeast Cells in Microencapsulation. General Features and Controlling Factors of the Encapsulation Process.

Authors:  Giulia Coradello; Nicola Tirelli
Journal:  Molecules       Date:  2021-05-24       Impact factor: 4.411

10.  Yeast Particle Encapsulation of Scaffolded Terpene Compounds for Controlled Terpene Release.

Authors:  Ernesto R Soto; Florentina Rus; Hanchen Li; Carli Garceau; Jeffrey Chicca; Mostafa Elfawal; David Gazzola; Martin K Nielsen; Joseph F Urban; Raffi V Aroian; Gary R Ostroff
Journal:  Foods       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.